Belderbos Tim D G, Leenders Max, Moons Leon M G, Siersema Peter D
Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Endoscopy. 2014 May;46(5):388-402. doi: 10.1055/s-0034-1364970. Epub 2014 Mar 26.
Local recurrence has been observed after endoscopic mucosal resection (EMR) of nonpedunculated colorectal lesions. The indications for follow-up colonoscopy and the optimal time interval are currently unclear. The aims of this systematic review were to assess the frequency of local recurrence after EMR, to identify risk factors for recurrence, and to provide follow-up recommendations.
A literature search was performed in PubMed, EMBASE, and the Cochrane Library. EMR was defined as endoscopic snare resection after submucosal fluid injection for removal of nonpedunculated adenomas and early carcinomas. Local recurrence was subdivided into early recurrence (detected at the first follow-up colonoscopy) and late recurrence (detected after ≥ 1 previous normal colonoscopy). A random effects meta-analysis was performed to calculate the pooled estimate of risk of recurrence.
A total of 33 studies were included. The mean recurrence risk after EMR was 15 % (95 % confidence interval [CI] 12 % - 19 %). Recurrence risk was higher after piecemeal resection (20 %; 95 %CI 16 % - 25 %) than after en bloc resection (3 %; 95 %CI 2 % - 5 %; P < 0.0001). In 15 studies that differentiated between early and late recurrences, 152/173 recurrences (88 %) occurred early. In four studies with follow-up at 3, 6, and ≥ 12 months, 19/25 (76 %) recurrences were detected at 3 months, increasing to 24 (96 %) at 6 months. In multivariable analysis, only piecemeal resection was associated with recurrence (3 of 3 studies).
Local recurrence after EMR of nonpedunculated colorectal lesions occurs in 3 % of en bloc resections and 20 % of piecemeal resections. Piecemeal resection was the only independent risk factor for recurrence. As more than 90 % of recurrences are detected at 6 months after EMR, we propose that 6 months is the optimal initial follow-up interval.
在内镜黏膜切除术(EMR)治疗无蒂结直肠病变后,观察到局部复发情况。目前,随访结肠镜检查的指征及最佳时间间隔尚不清楚。本系统评价的目的是评估EMR后局部复发的频率,确定复发的危险因素,并提供随访建议。
在PubMed、EMBASE和Cochrane图书馆进行文献检索。EMR定义为在黏膜下注射液体后通过内镜圈套切除术切除无蒂腺瘤和早期癌。局部复发分为早期复发(在首次随访结肠镜检查时发现)和晚期复发(在≥1次先前结肠镜检查正常后发现)。进行随机效应荟萃分析以计算复发风险的合并估计值。
共纳入33项研究。EMR后的平均复发风险为15%(95%置信区间[CI] 12% - 19%)。分块切除后的复发风险(20%;95%CI 16% - 25%)高于整块切除后(3%;95%CI 2% - 5%;P < 0.0001)。在15项区分早期和晚期复发的研究中,152/173例复发(88%)为早期复发。在4项随访时间为3、6和≥12个月的研究中,19/25例(76%)复发在3个月时被发现,6个月时增至24例(96%)。在多变量分析中,只有分块切除与复发相关(3项研究中的3项)。
无蒂结直肠病变EMR后的局部复发在整块切除中发生率为3%,在分块切除中为20%。分块切除是复发的唯一独立危险因素。由于超过90%的复发在EMR后6个月时被发现,我们建议6个月是最佳的初始随访间隔。